TXG: 10x Genomics, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 10 sales totaling $2.50M in the last 180 days.
Insider sales
| Trade date | Insider | Role | Value | 10b5-1 plan |
|---|---|---|---|---|
| 2026-09-22 | Suliman Shehnaaz | Director | $23K | yes |
| 2026-09-22 | Suliman Shehnaaz | Director | $49K | yes |
| 2026-09-22 | Suliman Shehnaaz | Director | $107K | yes |
| 2026-09-22 | Suliman Shehnaaz | Director | $185K | yes |
| 2026-09-22 | Suliman Shehnaaz | Director | $101K | yes |
| 2026-09-22 | Saxonov Serge | CEO | $78K | yes |
| 2026-09-22 | Saxonov Serge | CEO | $159K | yes |
| 2026-09-22 | Saxonov Serge | CEO | $752K | yes |
| 2026-09-22 | Saxonov Serge | CEO | $810K | yes |
| 2026-09-22 | Saxonov Serge | CEO | $231K | yes |
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-10-07 | 13G amendment | ARK Investment Management LLC | 5.22% | SEC | |
| 2026-09-08 | New 13G stake | T. Rowe Price Associates, Inc. | 11.70% | SEC |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.